Related Experiment Video
Updated: Jul 15, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
MELD 3.0 in Advanced Chronic Liver Disease
Nikhilesh R Mazumder1,2, Robert J Fontana1
1Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA; email: mazumde@med.umich.edu, rfontana@med.umich.edu.
The new Model for End-Stage Liver Disease (MELD) 3.0 score improves liver transplant candidate prioritization. This updated score is expected to reduce waitlist deaths and enhance access for female patients.
Area of Science:
- Hepatology
- Transplantation Medicine
- Medical Informatics
Background:
- The Model for End-Stage Liver Disease (MELD) score is crucial for liver transplant allocation.
- The current MELD-Sodium (MELD-Na) score has limitations in prioritizing patients.
- A revised scoring system is needed to improve accuracy and equity.
Purpose of the Study:
- To introduce and review the MELD 3.0 score, a successor to MELD-Na.
- To explain the updated components and weighting of the MELD 3.0 score.
- To discuss the anticipated impact of MELD 3.0 on liver allocation and patient outcomes.
Main Methods:
- Development of the MELD 3.0 score incorporating new variables.
- Inclusion of patient sex and serum albumin levels.
- Revised weighting for serum sodium, bilirubin, international normalized ratio, and creatinine.
Main Results:
- MELD 3.0 is designed to replace the MELD-Na score for liver allocation.
- The new score is expected to modestly decrease waitlist mortality.
- MELD 3.0 aims to improve access to liver transplantation for female candidates.
Conclusions:
- MELD 3.0 represents an advancement in risk stratification for liver transplant candidates.
- Further research is needed to evaluate MELD 3.0 and PELDcre in other clinical scenarios.
- This updated tool has the potential to optimize liver allocation and improve patient outcomes.
More Related Videos
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Kidney Disease IV: Nursing Management
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

